Compared with other antidiabetes medications, semaglutide linked to lower risk for patients with comorbid opioid use disorder
Findings seen among veterans, particularly young veterans, with comorbid PTSD and diabetes
No significant increase seen with use of GLP-1 RAs versus SGLT2is or DPP4is among older Medicare beneficiaries
No increased risk for suicidal ideation seen with semaglutide versus non-GLP1R agonist antiobesity medications
One-third of bed-days for patients diagnosed before age 40 years are for mental health
Genetic evidence does not support protective effects of modest alcohol consumption on obesity traits, T2D
Reduction in risk was greatest for those with history of ischemic heart disease or stroke
Among individuals with type 2 diabetes, country-standardized cognitive score may predict risk for cardiovascular events
Prevalence estimates of type 2 diabetes 40 percent for those with sleep disorder, 21 percent for binge eating disorder
Nearly one in four people with type 2 diabetes in Scotland were prescribed antidepressants before a diabetes diagnosis